In tumor biopsies, ITIH3 mRNA is reduced in tumor versus normal tissue in breast, uterus, colon, ovary, lung, rectum, and prostate cancer [48, 49], and low protein levels were significantly associated with poor prognosis and platinum resistance in ovarian cancer [49]. Here, ITIH3 is linked to prostate cancer.